The COVID 19 vaccine patent race
preprint
OA: closed
Abstract
COVID 19 has kept the world in its grip over the last 2 years already. It came with some remarkable - and in part concerning - developments, including the speed with which the virus, SARS CoV 2, spread over the globe, the fast vaccine development and approaval, the unexpected vaccine skepticism, and finally the inquitable distribution of the vaccines in different regions of the world. COVID 19 is also historic in terms of its patent background. The author has discussed different aspects thereof already.[1][2] In this article, the race to the vaccine, and its patents, will be discussed in detail.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00